Science Dec 29, 2023 Can we optimize lifestyle and medication according to our microbiota? Why do some people stay fit and healthy easier than others? A talk by Sofia Forslund-Startceva at the 37th Chaos Communication Congress (C7C3) in Hamburg.
Science Dec 27, 2023 New agent regulates serotonin production Diseases can emerge when the body’s production of serotonin is out of whack. Researchers led by Michael Bader from the Max Delbrück Center have discovered a therapeutic agent that brings down high levels of this hormone. Their start-up, Trypto Therapeutics, aims to develop the drug for the market.
Institute & Campus Dec 21, 2023 Supporting trainees right from the start About 30 young people are currently pursuing vocational training or a dual-study program at the Max Delbrück Center. Christiane Busch is one of their instructors. She welcomes the trainees, supports them during their time at the Max Delbrück Center, and finally sends them off into professional life.
Science Dec 21, 2023 Three questions for Ulrika Beitnere Ulrika Beitnere joined the Max Delbrück Center as a senior scientist in Maike Sander’s group, re-establishing the lab and uncovering mechanisms in diabetes. Previously, she worked at UC Davis on a rare disorder called Angelman syndrome. Helmholtz Monthly spoke to her for its “1 in 45,000” series.
Institute & Campus Dec 20, 2023 Designing climate-friendly research infrastructures Scientific infrastructure is highly specialized and energy-intensive. During a kick-off event of the Helmholtz Competence Network for Climate-Friendly Construction in Berlin, experts from both the Helmholtz centers and the construction industry discussed how it can be designed to be climate-friendly.
Science Dec 19, 2023 Taking out the cellular trash If waste DNA or RNA remains in cells, it can lead to diseases such as Alzheimer’s and autoimmune conditions. Writing in Nucleic Acids Research, scientists led by Oliver Daumke of the Max Delbrück Center describe the role one enzyme plays in removing this waste.
Press release Dec 19, 2023 A neuromuscular model for drug development In neuromuscular diseases, neurons and muscle cells stop communicating properly. Researchers led by Mina Gouti can now model this in 2D in a culture dish. Writing about their findings in “Nature Communications”, they say the new model promises to revolutionize high-throughput drug screening studies.
Institute & Campus Dec 08, 2023 “I gained self-confidence in New York” Working in Berlin-Mitte and New York – Lena Nitsch conducts research at both the MDC-BIMSB and New York University. For “We at the MDC”, the doctoral student discusses how it is to work in two labs, her experiences in the United States, and what she has learned through the “MDC-NYU PhD Exchange Program”.
Institute & Campus Dec 05, 2023 Leif Ludwig is named EMBO Young Investigator The European Molecular Biology Organization has selected Leif. S. Ludwig from the Berlin Institute of Health at Charité (BIH) and the Max Delbrück Center to become an EMBO Young Investigator. The program provides support to outstanding young life scientists.
The Guardian / 18. March 2024 ‘We actually don’t know much’: the scientists trying to close the knowledge gap in trans healthcare